Crescel, a Florida-based science and technology company, has announced the publication of a peer-reviewed, PubMed-indexed clinical study in the Journal of Cosmetic Dermatology, which demonstrates the efficacy of the brand's proprietary biobotanical microemulsion technology.
Delivered through the Crescel Skin Renewal Cream, the proprietary biobotanical microemulsion technology produces statistically superior outcomes compared to the leading prescription standard of care for rosacea. This is scientifically proven in the randomized, double-blind, controlled trial. The data showed that the cream reduced facial redness by 54% versus 23% for the pharmaceutical comparator, and decreased inflammatory lesions by 74% compared to 17% for the prescription product. The innovation achieved these results while maintaining an excellent safety profile with no reported negative side effects.
For the estimated 400 million individuals worldwide affected by this chronic inflammatory skin condition, Crescel's innovation is sure to appeal with its efficacy.
Image Credit: Crescel
What's Driving This Trend
- Biobotanical Microemulsions
- Plant-derived actives delivered through microemulsion systems create space for high-efficacy skincare products that rival prescription treatments with gentler safety profiles.
- Clinical-grade Cosmetics
- Peer-reviewed cosmetic formulations are blurring the line between beauty and medicine, opening new value in evidence-backed products for chronic skin concerns.
- Rosacea-focused Skincare
- Condition-specific creams with measurable redness and lesion reduction signal expanding demand for targeted dermatology alternatives beyond traditional pharmaceuticals.
Who This Affects Most
- Dermatology
- Non-prescription technologies with clinically superior outcomes could reshape treatment pathways for inflammatory skin conditions and patient-first care models.
- Cosmetics
- Scientific validation is elevating premium skincare brands, creating differentiation through trial-backed efficacy rather than ingredient storytelling alone.
- Biotechnology
- Advanced delivery platforms for botanical compounds highlight commercial potential in merging natural ingredients with pharmaceutical-level performance standards.
